Alpha Tau Medical
DRTS
14 hedge funds and large institutions have $5.92M invested in Alpha Tau Medical in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
17% more funds holding
Funds holding: 12 → 14 (+2)
12% more capital invested
Capital invested by funds: $5.28M → $5.92M (+$639K)
0.67% less ownership
Funds ownership: 1.63% → 0.95% (-0.67%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$795K |
| 2 |
JP Morgan Chase
New York
|
+$693K |
| 3 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$464K |
| 4 |
FAM
Fred Alger Management
New York
|
+$184K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$181K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$553K |
| 2 |
Capstone Investment Advisors
New York
|
-$188K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$185K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$36K |
| 5 |
CS
Clear Street
New York
|
-$30K |
DRTS Hedge Fund Activity: Q2 2022 in Review
14 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q2 2022, worth a combined $5.92M — up 12% from $5.28M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DRTS positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was ETF Managers Group, opening a new position worth an estimated $795K. The largest seller was Barclays, cutting an estimated $553K.
- 14 institutional investors held Alpha Tau Medical (DRTS) as of Q2 2022, up from 12 in Q1 2022.
- Funds reported $5.92M of Alpha Tau Medical stock for Q2 2022, up 12% quarter-over-quarter.
- 7 funds opened new Alpha Tau Medical positions in Q2 2022 and 5 closed out, a net change of +2 holders.
- The largest Alpha Tau Medical buyer in Q2 2022 was ETF Managers Group, an estimated $795K added.
- The largest Alpha Tau Medical seller in Q2 2022 was Barclays, an estimated $553K sold.
Based on aggregated 13F filings for Q2 2022.